Intravenous Solutions Market Overall Study Report 2021-2028 | Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols

According to the new report released, the global intravenous solution market was valued at US$ 8,372.0 million in 2019 and is expected to grow at a CAGR of 6.1 % during the forecast period of 2019-2027. Increasing prevalence of kidney failure is expected to lead to higher use of dialysis treatments, propelling the global intravenous solution market growth during the forecast period. Kidney failure is a disorder in which the kidneys' ability to eliminate waste and excess fluids from the body declines to function. In such situations, a dialysis operation is suggested. For instance, according to the National Kidney Foundation Factsheet, chronic kidney disease (CKD) impacted around 10% of the global population in March 2015, with around 2 million people receiving treatment for kidney failure. Furthermore, the National Institute of Health (NIH) estimates that 661,000 individuals in the U.S. had kidney failure in December 2016. Around 468,000 of these patients were on dialysis, and 193,000 underwent kidney transplant surgery.

Request Here For Market Latest Insights(PDF): https://www.coherentmarketinsights.com/insight/request-pdf/1134

According to the same source, hemodialysis was used to treat 88.2 % of end-stage renal disease patients in the U.S. In 2013, 9.0% of these individuals were on peritoneal dialysis, while 2.6 % underwent a kidney transplant.

Major market companies are concentrating their efforts on developing solutions that improve patient safety and reduce IV medication administration errors, hence reducing pain and preventing patient injury. For instance, at the European Association of Hospital Pharmacists Congress in France in March 2017, Becton, Dickinson, and Company introduced an IV Medication Safety Solution. This product was created to help prevent IV drug administration errors.

Key Takeaways of the global Intravenous Solution Market:

Due to an increase in the prevalence of kidney failure and dialysis, the global intravenous solution market is expected to grow at a CAGR of 6.1 % over the forecast period (2019–2027)

Due to an increase in the prevalence rate of kidney failure and dialysis, the global intravenous solution market is expected to grow at a CAGR of 6.1 % over the forecast period (2019–2027).

Due to rising global incidence of gastroenteritis, the saline solution segment is expected to account for the largest revenue share in 2027. According to the Global Burden of Disease Study, there have been two billion occurrences of gastroenteritis worldwide in 2015, resulting in 1.3 million deaths.

Purchase this Report - https://www.coherentmarketinsights.com/insight/buy-now/1134

Intravenous Solutions Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Other Reports:

U.S. Dental Membrane And Bone Graft Substitutes Market - https://www.coherentmarketinsights.com/press-release/us-dental-membrane-and-bone-graft-substitutes-market-3994

Dysphagia Management Market - https://www.coherentmarketinsights.com/press-release/dysphagia-management-market-2911

This release was published on openPR.